Stay updated on Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial
Sign up to get notified when there's something new on the Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial page.

Latest updates to the Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial page
- Check6 days agoChange DetectedPublications section updated: added a 2025 AIDS article by D'Amico et al. and removed the 2025 July online-ahead-of-print entry for the same study. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe publications are automatically filled in from PubMed, and Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check28 days agoChange DetectedThe page no longer shows the government funding notice about operating status. Core study details, design, endpoints, and locations are unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check35 days agoChange DetectedAdded a new AIDS publication citation for D’Amico et al. (AIDS, 2025 Jul 31; online ahead of print) and removed a version of the same citation with a different author list/date (AIDS, 2025 Aug 8).SummaryDifference0.0%

- Check42 days agoChange DetectedContent and data on the Study Details page appear unchanged between the two screenshots; only layout or display formatting differences are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check71 days agoChange DetectedMajor update: page now includes a government funding/operating-status notice (high-importance core content) and switches from version v3.1.0 to v3.2.0.SummaryDifference0.7%

Stay in the know with updates to Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial page.